Options360

Options360

Bullish for near term on Cassava Sciences. What can I say, SAVA went through the roof the past 2 weeks. News on big insider purchases by it's chief financial officer & chief executive officer and positive data on it's Alzheimer's drug has nearly quadrupled it's share price in 10 trading days. From a share price of $3.32 close on Friday 9/11, to a high of $12.34...

Options360

Get ready for a transition into value over the next 2 weeks. The confirmation for this pattern is a close above the upper descending trendline on above average daily volume (10M). Regardless of the exact day to enter this week 9/28, current entry point ($57.32 9/25 close) is fantastic with little historical risk on the down side below $60 anyhow. Once this bullish...